The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

OBJECTIVES: The interaction between the immune system and tumor cells is an important feature for the prognosis and treatment of cancer. Multiplex immunohistochemistry (mIHC) and multiplex immunofluorescence (mIF) analyses are emerging technologies that can be used to help quantify immune cell subse...

Descripción completa

Detalles Bibliográficos
Autores principales: Taube, Janis M, Akturk, Guray, Angelo, Michael, Engle, Elizabeth L, Gnjatic, Sacha, Greenbaum, Shirley, Greenwald, Noah F, Hedvat, Cyrus V, Hollmann, Travis J, Juco, Jonathan, Parra, Edwin R, Rebelatto, Marlon C, Rimm, David L, Rodriguez-Canales, Jaime, Schalper, Kurt A, Stack, Edward C, Ferreira, Cláudia S, Korski, Konstanty, Lako, Ana, Rodig, Scott J, Schenck, Emanuel, Steele, Keith E, Surace, Michael J, Tetzlaff, Michael T, von Loga, Katharina, Wistuba, Ignacio I, Bifulco, Carlo B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239569/
https://www.ncbi.nlm.nih.gov/pubmed/32414858
http://dx.doi.org/10.1136/jitc-2019-000155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239569/
https://www.ncbi.nlm.nih.gov/pubmed/32414858
http://dx.doi.org/10.1136/jitc-2019-000155

Ejemplares similares